Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Critical Illness | 75 | 2024 | 2756 | 10.850 |
Why?
|
Enteral Nutrition | 41 | 2024 | 802 | 10.000 |
Why?
|
Intensive Care Units, Pediatric | 56 | 2025 | 1027 | 8.020 |
Why?
|
Nutritional Support | 15 | 2024 | 178 | 5.380 |
Why?
|
Parenteral Nutrition | 27 | 2024 | 663 | 4.840 |
Why?
|
Nutritional Status | 33 | 2024 | 1628 | 4.460 |
Why?
|
Calorimetry, Indirect | 20 | 2020 | 176 | 3.700 |
Why?
|
Respiration, Artificial | 30 | 2025 | 2726 | 3.690 |
Why?
|
Energy Intake | 28 | 2024 | 2146 | 3.650 |
Why?
|
Dietary Proteins | 16 | 2024 | 960 | 2.770 |
Why?
|
Critical Care | 24 | 2024 | 2715 | 2.490 |
Why?
|
Energy Metabolism | 23 | 2023 | 2907 | 2.370 |
Why?
|
Nutrition Therapy | 5 | 2021 | 101 | 2.290 |
Why?
|
Nutritional Requirements | 14 | 2024 | 279 | 2.280 |
Why?
|
Nutrition Assessment | 14 | 2024 | 740 | 2.000 |
Why?
|
Pulmonary Gas Exchange | 6 | 2015 | 389 | 1.810 |
Why?
|
Basal Metabolism | 7 | 2016 | 163 | 1.770 |
Why?
|
Child | 109 | 2024 | 80917 | 1.730 |
Why?
|
Malnutrition | 11 | 2023 | 632 | 1.730 |
Why?
|
Oxygen Consumption | 7 | 2017 | 1880 | 1.620 |
Why?
|
Capnography | 3 | 2017 | 90 | 1.480 |
Why?
|
Peptic Ulcer | 2 | 2024 | 214 | 1.430 |
Why?
|
Carbon Dioxide | 7 | 2017 | 1148 | 1.420 |
Why?
|
Body Composition | 9 | 2020 | 2462 | 1.370 |
Why?
|
Gastric Emptying | 5 | 2021 | 247 | 1.340 |
Why?
|
Child Nutritional Physiological Phenomena | 4 | 2018 | 294 | 1.170 |
Why?
|
Child Nutrition Disorders | 7 | 2019 | 140 | 1.170 |
Why?
|
Sepsis | 9 | 2022 | 2608 | 1.150 |
Why?
|
Child, Preschool | 56 | 2024 | 42669 | 1.110 |
Why?
|
Infant | 55 | 2024 | 36535 | 1.060 |
Why?
|
Electric Impedance | 4 | 2017 | 794 | 0.930 |
Why?
|
Muscular Atrophy, Spinal | 2 | 2018 | 260 | 0.870 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2018 | 1483 | 0.840 |
Why?
|
Dielectric Spectroscopy | 1 | 2022 | 32 | 0.800 |
Why?
|
Pediatrics | 9 | 2020 | 3629 | 0.790 |
Why?
|
Stomach | 2 | 2017 | 701 | 0.770 |
Why?
|
Micronutrients | 2 | 2018 | 390 | 0.760 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2022 | 111 | 0.750 |
Why?
|
Child, Hospitalized | 2 | 2023 | 182 | 0.720 |
Why?
|
Nutritional Physiological Phenomena | 2 | 2020 | 360 | 0.720 |
Why?
|
Gastroparesis | 2 | 2020 | 143 | 0.710 |
Why?
|
Heart Defects, Congenital | 5 | 2024 | 4712 | 0.700 |
Why?
|
Humans | 148 | 2025 | 768166 | 0.700 |
Why?
|
Rest | 6 | 2021 | 948 | 0.690 |
Why?
|
Quadriceps Muscle | 2 | 2021 | 157 | 0.680 |
Why?
|
Midazolam | 1 | 2021 | 267 | 0.670 |
Why?
|
Anti-Ulcer Agents | 1 | 2020 | 112 | 0.660 |
Why?
|
Gastrointestinal Hormones | 1 | 2019 | 101 | 0.630 |
Why?
|
Histamine H2 Antagonists | 1 | 2020 | 169 | 0.630 |
Why?
|
Ascorbic Acid | 1 | 2022 | 658 | 0.620 |
Why?
|
Shock, Septic | 3 | 2020 | 774 | 0.620 |
Why?
|
Methylhistidines | 1 | 2017 | 35 | 0.600 |
Why?
|
Adolescent | 45 | 2024 | 89169 | 0.590 |
Why?
|
Pilot Projects | 11 | 2024 | 8741 | 0.560 |
Why?
|
Teaching Rounds | 1 | 2021 | 282 | 0.560 |
Why?
|
Length of Stay | 17 | 2021 | 6498 | 0.550 |
Why?
|
Analgesia | 1 | 2021 | 460 | 0.550 |
Why?
|
Body Mass Index | 14 | 2023 | 13053 | 0.550 |
Why?
|
Gastroschisis | 1 | 2018 | 99 | 0.550 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2024 | 1126 | 0.550 |
Why?
|
Societies, Medical | 4 | 2018 | 3968 | 0.540 |
Why?
|
Absorptiometry, Photon | 3 | 2018 | 1758 | 0.540 |
Why?
|
Prospective Studies | 30 | 2024 | 54926 | 0.540 |
Why?
|
Antacids | 1 | 2016 | 94 | 0.530 |
Why?
|
Thigh | 1 | 2017 | 238 | 0.520 |
Why?
|
Haptoglobins | 3 | 2022 | 165 | 0.520 |
Why?
|
Hospital Mortality | 5 | 2024 | 5349 | 0.510 |
Why?
|
Sarcopenia | 1 | 2021 | 378 | 0.510 |
Why?
|
Breath Tests | 1 | 2017 | 300 | 0.500 |
Why?
|
Interleukin-10 | 1 | 2020 | 1183 | 0.470 |
Why?
|
Hospitalization | 7 | 2023 | 10840 | 0.470 |
Why?
|
Deuterium | 1 | 2014 | 106 | 0.460 |
Why?
|
Respiratory Insufficiency | 2 | 2015 | 1240 | 0.460 |
Why?
|
Stomach Diseases | 1 | 2015 | 134 | 0.460 |
Why?
|
Body Weight | 7 | 2023 | 4627 | 0.460 |
Why?
|
Glycine | 1 | 2017 | 672 | 0.460 |
Why?
|
Male | 65 | 2024 | 364719 | 0.450 |
Why?
|
Thoracic Surgical Procedures | 1 | 2017 | 350 | 0.440 |
Why?
|
Anthropometry | 5 | 2023 | 1346 | 0.440 |
Why?
|
Research | 2 | 2018 | 1979 | 0.430 |
Why?
|
Infant, Newborn | 23 | 2023 | 26422 | 0.420 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2016 | 278 | 0.420 |
Why?
|
Proteins | 4 | 2020 | 6009 | 0.410 |
Why?
|
Female | 67 | 2024 | 397192 | 0.410 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1178 | 0.390 |
Why?
|
Creatinine | 1 | 2017 | 1918 | 0.390 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2014 | 352 | 0.390 |
Why?
|
Home Care Services | 2 | 2015 | 659 | 0.380 |
Why?
|
Nursing Staff, Hospital | 1 | 2015 | 350 | 0.380 |
Why?
|
Overnutrition | 1 | 2011 | 25 | 0.380 |
Why?
|
Cross Infection | 5 | 2022 | 1426 | 0.380 |
Why?
|
Medical Staff, Hospital | 1 | 2015 | 603 | 0.360 |
Why?
|
Short Bowel Syndrome | 1 | 2014 | 352 | 0.360 |
Why?
|
Algorithms | 6 | 2024 | 14164 | 0.360 |
Why?
|
Point-of-Care Systems | 3 | 2020 | 1238 | 0.360 |
Why?
|
Stress, Physiological | 2 | 2014 | 1408 | 0.330 |
Why?
|
Gastrointestinal Diseases | 2 | 2024 | 1206 | 0.330 |
Why?
|
Multiple Organ Failure | 3 | 2024 | 388 | 0.330 |
Why?
|
Monitoring, Physiologic | 2 | 2014 | 1798 | 0.330 |
Why?
|
Gastrointestinal Transit | 2 | 2021 | 101 | 0.310 |
Why?
|
Protein Precursors | 3 | 2022 | 1134 | 0.310 |
Why?
|
Intensive Care Units | 5 | 2023 | 3800 | 0.300 |
Why?
|
Overweight | 2 | 2016 | 2448 | 0.300 |
Why?
|
Dietary Supplements | 2 | 2018 | 3445 | 0.300 |
Why?
|
Body Water | 2 | 2022 | 340 | 0.290 |
Why?
|
Weight Gain | 1 | 2018 | 2359 | 0.290 |
Why?
|
Infant, Newborn, Diseases | 1 | 2012 | 587 | 0.280 |
Why?
|
Pharmacokinetics | 1 | 2007 | 86 | 0.280 |
Why?
|
Retrospective Studies | 19 | 2024 | 81762 | 0.270 |
Why?
|
Parenteral Nutrition, Total | 2 | 2018 | 304 | 0.260 |
Why?
|
Program Evaluation | 1 | 2015 | 2507 | 0.260 |
Why?
|
Burns | 1 | 2017 | 1899 | 0.260 |
Why?
|
Consensus | 5 | 2020 | 3212 | 0.250 |
Why?
|
Fontan Procedure | 1 | 2012 | 805 | 0.250 |
Why?
|
Uteroglobin | 1 | 2005 | 56 | 0.250 |
Why?
|
DNA Methylation | 1 | 2020 | 4428 | 0.250 |
Why?
|
Adipose Tissue | 1 | 2017 | 3329 | 0.250 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2008 | 270 | 0.250 |
Why?
|
Hypnotics and Sedatives | 2 | 2025 | 1191 | 0.240 |
Why?
|
Practice Guidelines as Topic | 4 | 2024 | 7454 | 0.240 |
Why?
|
Chronic Disease | 3 | 2024 | 9384 | 0.240 |
Why?
|
Feasibility Studies | 4 | 2021 | 5315 | 0.230 |
Why?
|
Postoperative Complications | 3 | 2017 | 15832 | 0.230 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2008 | 359 | 0.230 |
Why?
|
Reproducibility of Results | 8 | 2024 | 20227 | 0.220 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 79 | 0.220 |
Why?
|
Guidelines as Topic | 2 | 2020 | 1397 | 0.210 |
Why?
|
Time Factors | 11 | 2021 | 40218 | 0.210 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2002 | 12 | 0.210 |
Why?
|
Biomedical Research | 1 | 2018 | 3463 | 0.200 |
Why?
|
Ulcer | 1 | 2024 | 203 | 0.200 |
Why?
|
Obesity | 3 | 2016 | 13090 | 0.200 |
Why?
|
Rubella | 1 | 2002 | 55 | 0.200 |
Why?
|
Evidence-Based Practice | 2 | 2018 | 500 | 0.190 |
Why?
|
Body Height | 3 | 2023 | 1565 | 0.190 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2002 | 101 | 0.190 |
Why?
|
Cholinergic Antagonists | 1 | 2021 | 167 | 0.180 |
Why?
|
Reference Values | 2 | 2021 | 4938 | 0.180 |
Why?
|
Meningitis, Meningococcal | 1 | 2000 | 43 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 2 | 2013 | 3683 | 0.170 |
Why?
|
Resuscitation | 2 | 2022 | 679 | 0.170 |
Why?
|
Meningococcal Infections | 1 | 2000 | 78 | 0.170 |
Why?
|
Skinfold Thickness | 2 | 2017 | 164 | 0.170 |
Why?
|
Polyvinyls | 1 | 2021 | 154 | 0.170 |
Why?
|
Quality of Life | 1 | 2021 | 13490 | 0.170 |
Why?
|
Dietary Carbohydrates | 3 | 2016 | 896 | 0.170 |
Why?
|
Heart Ventricles | 1 | 2012 | 3841 | 0.170 |
Why?
|
Cohort Studies | 8 | 2022 | 41754 | 0.170 |
Why?
|
Spectrum Analysis | 1 | 2021 | 449 | 0.170 |
Why?
|
Tachycardia, Supraventricular | 1 | 2022 | 273 | 0.160 |
Why?
|
Heart Diseases | 1 | 2012 | 2819 | 0.160 |
Why?
|
Hyperglycemia | 2 | 2020 | 1388 | 0.160 |
Why?
|
Lipoma | 1 | 2001 | 296 | 0.160 |
Why?
|
Pharmaceutical Preparations | 1 | 2007 | 1088 | 0.160 |
Why?
|
Intubation, Gastrointestinal | 1 | 2020 | 166 | 0.160 |
Why?
|
Prevalence | 5 | 2022 | 15869 | 0.150 |
Why?
|
Prescriptions | 1 | 2021 | 388 | 0.150 |
Why?
|
Esophageal Atresia | 1 | 2021 | 226 | 0.150 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2020 | 264 | 0.150 |
Why?
|
Republic of Korea | 1 | 2020 | 591 | 0.150 |
Why?
|
Hyperinsulinism | 1 | 2001 | 402 | 0.150 |
Why?
|
Nitrogen Isotopes | 1 | 2017 | 82 | 0.150 |
Why?
|
Medication Errors | 1 | 2024 | 786 | 0.140 |
Why?
|
Treatment Outcome | 10 | 2024 | 65371 | 0.140 |
Why?
|
Respiration Disorders | 1 | 2000 | 364 | 0.140 |
Why?
|
Postoperative Period | 1 | 2022 | 1826 | 0.140 |
Why?
|
High-Frequency Ventilation | 2 | 2010 | 90 | 0.140 |
Why?
|
United Arab Emirates | 1 | 2016 | 42 | 0.140 |
Why?
|
Protein-Energy Malnutrition | 1 | 2018 | 189 | 0.140 |
Why?
|
Gastrointestinal Contents | 1 | 2017 | 42 | 0.140 |
Why?
|
Ammonia | 1 | 2017 | 247 | 0.140 |
Why?
|
Malaysia | 1 | 2016 | 107 | 0.140 |
Why?
|
Catheterization, Central Venous | 1 | 2002 | 537 | 0.140 |
Why?
|
Models, Biological | 1 | 2013 | 9495 | 0.140 |
Why?
|
Indonesia | 1 | 2016 | 131 | 0.130 |
Why?
|
Oxygen | 2 | 2023 | 4270 | 0.130 |
Why?
|
Anesthetics, Intravenous | 1 | 1999 | 397 | 0.130 |
Why?
|
Saudi Arabia | 1 | 2016 | 212 | 0.130 |
Why?
|
Intensive Care, Neonatal | 1 | 2018 | 200 | 0.130 |
Why?
|
Thailand | 1 | 2016 | 288 | 0.130 |
Why?
|
Corpus Callosum | 1 | 2001 | 753 | 0.130 |
Why?
|
Muscles | 1 | 2021 | 1582 | 0.130 |
Why?
|
Nitrogen | 2 | 2020 | 345 | 0.130 |
Why?
|
Feeding Methods | 1 | 2016 | 35 | 0.130 |
Why?
|
ROC Curve | 1 | 2024 | 3628 | 0.130 |
Why?
|
Singapore | 1 | 2016 | 300 | 0.130 |
Why?
|
Infant, Premature, Diseases | 1 | 2002 | 712 | 0.130 |
Why?
|
Brazil | 2 | 2019 | 1250 | 0.130 |
Why?
|
Linear Models | 3 | 2014 | 5884 | 0.130 |
Why?
|
Eating | 1 | 2022 | 1542 | 0.130 |
Why?
|
Urea | 1 | 2017 | 448 | 0.120 |
Why?
|
Angelman Syndrome | 1 | 2017 | 139 | 0.120 |
Why?
|
Tracheotomy | 1 | 2016 | 174 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 585 | 0.120 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4249 | 0.120 |
Why?
|
Infant, Small for Gestational Age | 1 | 2018 | 468 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10399 | 0.120 |
Why?
|
Logistic Models | 4 | 2016 | 13290 | 0.120 |
Why?
|
Lung Volume Measurements | 1 | 2015 | 381 | 0.120 |
Why?
|
Delphi Technique | 1 | 2018 | 891 | 0.120 |
Why?
|
Checklist | 1 | 2021 | 840 | 0.120 |
Why?
|
Inflammation | 3 | 2024 | 10873 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2001 | 837 | 0.110 |
Why?
|
Mathematical Concepts | 1 | 2014 | 75 | 0.110 |
Why?
|
Nutrition Policy | 1 | 2017 | 467 | 0.110 |
Why?
|
Vitamins | 1 | 2022 | 1638 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 26379 | 0.110 |
Why?
|
Propofol | 1 | 1999 | 608 | 0.110 |
Why?
|
Vomiting | 1 | 2017 | 655 | 0.110 |
Why?
|
Bacteremia | 1 | 2000 | 986 | 0.110 |
Why?
|
Pulmonary Ventilation | 1 | 2015 | 375 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1008 | 0.110 |
Why?
|
Australia | 1 | 2016 | 1265 | 0.100 |
Why?
|
Patient Discharge | 5 | 2023 | 3479 | 0.100 |
Why?
|
Thinness | 1 | 2016 | 483 | 0.100 |
Why?
|
Infant Nutrition Disorders | 1 | 2013 | 70 | 0.100 |
Why?
|
Acetaminophen | 1 | 2017 | 552 | 0.100 |
Why?
|
Area Under Curve | 1 | 2017 | 1643 | 0.100 |
Why?
|
Decision Trees | 1 | 2014 | 508 | 0.100 |
Why?
|
Weight Loss | 2 | 2018 | 2721 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14783 | 0.100 |
Why?
|
Medicine | 1 | 2020 | 945 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1365 | 0.100 |
Why?
|
Anemia, Sickle Cell | 1 | 2000 | 1065 | 0.100 |
Why?
|
Models, Anatomic | 1 | 2015 | 680 | 0.100 |
Why?
|
Lactic Acid | 2 | 2020 | 1140 | 0.100 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 14729 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1135 | 0.090 |
Why?
|
Young Adult | 6 | 2018 | 60066 | 0.090 |
Why?
|
Water-Electrolyte Balance | 1 | 2012 | 326 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39348 | 0.090 |
Why?
|
Abdomen | 1 | 2017 | 1136 | 0.090 |
Why?
|
Nutrition Disorders | 1 | 2011 | 204 | 0.090 |
Why?
|
Clinical Protocols | 2 | 2016 | 1443 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2017 | 1070 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2002 | 2185 | 0.090 |
Why?
|
Bronchiolitis | 1 | 2016 | 492 | 0.090 |
Why?
|
Feces | 1 | 2017 | 1511 | 0.090 |
Why?
|
India | 1 | 2016 | 2334 | 0.080 |
Why?
|
Intestinal Diseases | 1 | 2014 | 505 | 0.080 |
Why?
|
Birth Weight | 1 | 2018 | 2121 | 0.080 |
Why?
|
Blood Gas Analysis | 1 | 2010 | 384 | 0.080 |
Why?
|
United States | 7 | 2020 | 73039 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2665 | 0.080 |
Why?
|
Governing Board | 1 | 2009 | 50 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1942 | 0.080 |
Why?
|
Gestational Age | 1 | 2018 | 3621 | 0.080 |
Why?
|
Adult | 10 | 2018 | 223646 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2163 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15948 | 0.080 |
Why?
|
Quality Improvement | 1 | 2023 | 3857 | 0.080 |
Why?
|
Nutrition Surveys | 1 | 2016 | 1738 | 0.080 |
Why?
|
Perioperative Care | 1 | 2016 | 1043 | 0.070 |
Why?
|
Ultrasonography | 2 | 2021 | 6004 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2020 | 12465 | 0.070 |
Why?
|
Prognosis | 2 | 2024 | 30010 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2017 | 1901 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2024 | 4887 | 0.070 |
Why?
|
Adiposity | 2 | 2014 | 1895 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3139 | 0.070 |
Why?
|
Proteomics | 1 | 2021 | 3912 | 0.070 |
Why?
|
Dietary Fats | 2 | 2016 | 2003 | 0.070 |
Why?
|
Vasoconstrictor Agents | 2 | 2020 | 656 | 0.070 |
Why?
|
Fluid Therapy | 2 | 2020 | 587 | 0.060 |
Why?
|
ras Proteins | 1 | 2011 | 1058 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2486 | 0.060 |
Why?
|
Liver Diseases | 1 | 2014 | 1305 | 0.060 |
Why?
|
Respiration | 1 | 2012 | 1665 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2536 | 0.060 |
Why?
|
Probability | 1 | 2010 | 2479 | 0.060 |
Why?
|
Fractures, Bone | 1 | 2017 | 2062 | 0.060 |
Why?
|
Salvage Therapy | 1 | 2011 | 1273 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2998 | 0.060 |
Why?
|
Blood Glucose | 2 | 2016 | 6430 | 0.060 |
Why?
|
Gastrointestinal Tract | 2 | 2024 | 840 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2381 | 0.060 |
Why?
|
Interdisciplinary Communication | 1 | 2009 | 937 | 0.060 |
Why?
|
Risk Factors | 5 | 2017 | 74944 | 0.050 |
Why?
|
Computer Simulation | 1 | 2017 | 6283 | 0.050 |
Why?
|
Pulmonary Surfactants | 1 | 2004 | 169 | 0.050 |
Why?
|
Prone Position | 1 | 2004 | 203 | 0.050 |
Why?
|
Lung | 2 | 2015 | 10099 | 0.050 |
Why?
|
Ventilator Weaning | 1 | 2004 | 170 | 0.050 |
Why?
|
Sri Lanka | 1 | 2002 | 93 | 0.050 |
Why?
|
London | 1 | 2002 | 233 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12077 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18349 | 0.050 |
Why?
|
Peritoneal Cavity | 1 | 2002 | 135 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18412 | 0.050 |
Why?
|
Tidal Volume | 1 | 2004 | 518 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 326 | 0.050 |
Why?
|
Prostaglandins | 1 | 2022 | 398 | 0.050 |
Why?
|
Survival Rate | 2 | 2011 | 12840 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2001 | 9118 | 0.040 |
Why?
|
Goals | 1 | 2025 | 717 | 0.040 |
Why?
|
Hemodynamics | 2 | 2020 | 4194 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 282 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2004 | 713 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9613 | 0.040 |
Why?
|
Respiratory Aspiration | 1 | 2020 | 89 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2011 | 4528 | 0.040 |
Why?
|
Gastric Mucosa | 1 | 2021 | 602 | 0.040 |
Why?
|
Diet | 1 | 2016 | 8089 | 0.040 |
Why?
|
Albumins | 1 | 2020 | 577 | 0.040 |
Why?
|
Documentation | 1 | 2023 | 917 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 996 | 0.030 |
Why?
|
Hearing | 1 | 2001 | 504 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2017 | 369 | 0.030 |
Why?
|
Emergency Treatment | 1 | 2000 | 497 | 0.030 |
Why?
|
Travel | 1 | 2002 | 805 | 0.030 |
Why?
|
Specimen Handling | 1 | 2021 | 708 | 0.030 |
Why?
|
Dietetics | 1 | 2016 | 34 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2000 | 1836 | 0.030 |
Why?
|
Maze Learning | 1 | 2017 | 482 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 11879 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 916 | 0.030 |
Why?
|
Middle East | 1 | 2016 | 233 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2007 | 3573 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2130 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2146 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 2230 | 0.030 |
Why?
|
Prenatal Care | 1 | 2002 | 1162 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 744 | 0.030 |
Why?
|
Syndrome | 1 | 2000 | 3272 | 0.030 |
Why?
|
Asia | 1 | 2016 | 629 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15454 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2021 | 2219 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5717 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6395 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12543 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2415 | 0.030 |
Why?
|
San Francisco | 1 | 2013 | 166 | 0.030 |
Why?
|
Incidence | 1 | 2011 | 21538 | 0.030 |
Why?
|
Primary Prevention | 1 | 2000 | 1188 | 0.030 |
Why?
|
Guatemala | 1 | 2013 | 161 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2020 | 983 | 0.030 |
Why?
|
Infant, Premature | 1 | 2002 | 2124 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6974 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22379 | 0.020 |
Why?
|
Prealbumin | 1 | 2013 | 259 | 0.020 |
Why?
|
Genotype | 1 | 2005 | 13045 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2002 | 3216 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2025 | 3929 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3044 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2002 | 4568 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3228 | 0.020 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2014 | 327 | 0.020 |
Why?
|
Mental Recall | 1 | 2016 | 1226 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11878 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2013 | 542 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6340 | 0.020 |
Why?
|
Serum Albumin | 1 | 2013 | 677 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3886 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2011 | 408 | 0.020 |
Why?
|
Leucovorin | 1 | 2011 | 643 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9561 | 0.020 |
Why?
|
Otolaryngology | 1 | 2016 | 699 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 13014 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3858 | 0.020 |
Why?
|
Fear | 1 | 2017 | 1495 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2420 | 0.020 |
Why?
|
Vaccination | 1 | 2000 | 3437 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 8080 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3706 | 0.020 |
Why?
|
Siblings | 1 | 2012 | 828 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2208 | 0.020 |
Why?
|
Camptothecin | 1 | 2011 | 600 | 0.020 |
Why?
|
Motor Activity | 1 | 2017 | 2711 | 0.020 |
Why?
|
Curriculum | 1 | 2020 | 3782 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7453 | 0.020 |
Why?
|
Mutation | 1 | 2011 | 30238 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2020 | 3986 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5458 | 0.020 |
Why?
|
Fluorouracil | 1 | 2011 | 1652 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7243 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2016 | 2118 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1744 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6607 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 1751 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6211 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10632 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2012 | 4833 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1767 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14488 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7852 | 0.010 |
Why?
|
Electroencephalography | 1 | 2017 | 6314 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7477 | 0.010 |
Why?
|
Pregnancy | 1 | 2002 | 30256 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2012 | 1907 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16726 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22291 | 0.010 |
Why?
|
Animals | 2 | 2021 | 169246 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11244 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24315 | 0.010 |
Why?
|
Mice | 1 | 2021 | 82029 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9263 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2001 | 36743 | 0.010 |
Why?
|
Middle Aged | 1 | 2011 | 223492 | 0.000 |
Why?
|